Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review
Article
[키워드] accompanied
adverse event
antibodies
article
autoantibodies
autoantibody
BNT162b2
ChAdOx1
Clinical course
clinical feature
complications
composed
conducted
coronavirus disease
coronavirus disease 2019 vaccine
COVID-19
COVID-19 vaccination
COVID-19 vaccine
critical appraisal
dermatomyositis
Follow-up
identify
Immune-mediated
IMPROVE
independent
induce
Inflammatory
inflammatory myopathy
investigator
Joanna Briggs Institute
management
muscular
myositis
myositis specific autoantibodies.
occurred
Onset
Patient
patients
presenting
proportion
report
reported
Risk of bias
SARS-CoV-2
SARS-CoV-2 vaccine
searched
Side effect
skin rash
Specific
subtype
Symptom
systematic review
Treatment
vaccination
Vaccine
vaccine dose
weakness
were used
[DOI] 10.3389/fpubh.2022.1007637 PMC 바로가기
[DOI] 10.3389/fpubh.2022.1007637 PMC 바로가기